Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach.

Heerma van Voss MR, Kammers K, Vesuna F, Brilliant J, Bergman Y, Tantravedi S, Wu X, Cole RN, Holland A, van Diest PJ, Raman V.

Transl Oncol. 2018 Jun;11(3):755-763. doi: 10.1016/j.tranon.2018.04.001. Epub 2018 Apr 24.

2.

Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment.

Heerma van Voss MR, Vesuna F, Bol GM, Afzal J, Tantravedi S, Bergman Y, Kammers K, Lehar M, Malek R, Ballew M, Ter Hoeve N, Abou D, Thorek D, Berlinicke C, Yazdankhah M, Sinha D, Le A, Abrahams R, Tran PT, van Diest PJ, Raman V.

Oncogene. 2018 Jan 4;37(1):63-74. doi: 10.1038/onc.2017.308. Epub 2017 Sep 4.

3.

Importance of biomarkers in glioblastomas patients receiving local BCNU wafer chemotherapy.

Urbschat S, Sippl C, Engelhardt J, Kammers K, Oertel J, Ketter R.

Mol Cytogenet. 2017 May 4;10:16. doi: 10.1186/s13039-017-0317-5. eCollection 2017.

4.

Reproducible RNA-seq analysis using recount2.

Collado-Torres L, Nellore A, Kammers K, Ellis SE, Taub MA, Hansen KD, Jaffe AE, Langmead B, Leek JT.

Nat Biotechnol. 2017 Apr 11;35(4):319-321. doi: 10.1038/nbt.3838. No abstract available.

PMID:
28398307
5.

The benefit of adjuvant radiotherapy after breast conserving surgery in older patients with low risk breast cancer- a meta-analysis of randomized trials.

Matuschek C, Bölke E, Haussmann J, Mohrmann S, Nestle-Krämling C, Gerber PA, Corradini S, Orth K, Kammers K, Budach W.

Radiat Oncol. 2017 Mar 23;12(1):60. doi: 10.1186/s13014-017-0796-x.

6.

Integrity of Induced Pluripotent Stem Cell (iPSC) Derived Megakaryocytes as Assessed by Genetic and Transcriptomic Analysis.

Kammers K, Taub MA, Ruczinski I, Martin J, Yanek LR, Frazee A, Gao Y, Hoyle D, Faraday N, Becker DM, Cheng L, Wang ZZ, Leek JT, Becker LC, Mathias RA.

PLoS One. 2017 Jan 20;12(1):e0167794. doi: 10.1371/journal.pone.0167794. eCollection 2017.

7.

Quantitative Proteomic Analysis Reveals Similarities between Huntington's Disease (HD) and Huntington's Disease-Like 2 (HDL2) Human Brains.

Ratovitski T, Chaerkady R, Kammers K, Stewart JC, Zavala A, Pletnikova O, Troncoso JC, Rudnicki DD, Margolis RL, Cole RN, Ross CA.

J Proteome Res. 2016 Sep 2;15(9):3266-83. doi: 10.1021/acs.jproteome.6b00448. Epub 2016 Aug 3.

8.

Integrated Omic Analysis of a Guinea Pig Model of Heart Failure and Sudden Cardiac Death.

Foster DB, Liu T, Kammers K, O'Meally R, Yang N, Papanicolaou KN, Talbot CC Jr, Cole RN, O'Rourke B.

J Proteome Res. 2016 Sep 2;15(9):3009-28. doi: 10.1021/acs.jproteome.6b00149. Epub 2016 Aug 3.

9.

Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients.

Matuschek C, Bölke E, Geigis C, Kammers K, Ganswindt U, Scheckenbach K, Gripp S, Simiantonakis J, Hoffmann TK, Greve J, Gerber PA, Orth K, Roeder H, Hautmann MG, Budach W.

Radiother Oncol. 2016 Jul;120(1):28-35. doi: 10.1016/j.radonc.2016.05.017. Epub 2016 Jun 10.

PMID:
27296411
10.

Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials- an update.

Budach W, Bölke E, Kammers K, Gerber PA, Nestle-Krämling C, Matuschek C.

Radiat Oncol. 2015 Dec 21;10:258. doi: 10.1186/s13014-015-0568-4.

11.

Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.

Budach W, Bölke E, Kammers K, Gerber PA, Orth K, Gripp S, Matuschek C.

Radiother Oncol. 2016 Feb;118(2):238-43. doi: 10.1016/j.radonc.2015.10.014. Epub 2015 Nov 14.

PMID:
26589131
12.

RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma.

Wilky BA, Kim C, McCarty G, Montgomery EA, Kammers K, DeVine LR, Cole RN, Raman V, Loeb DM.

Oncogene. 2016 May 19;35(20):2574-83. doi: 10.1038/onc.2015.336. Epub 2015 Sep 14.

PMID:
26364611
13.

Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy.

te Riele AS, James CA, Groeneweg JA, Sawant AC, Kammers K, Murray B, Tichnell C, van der Heijden JF, Judge DP, Dooijes D, van Tintelen JP, Hauer RN, Calkins H, Tandri H.

Eur Heart J. 2016 Mar 1;37(9):755-63. doi: 10.1093/eurheartj/ehv387. Epub 2015 Aug 27.

PMID:
26314686
14.

Effects of Radiotherapy in the treatment of multiple myeloma: a retrospective analysis of a Single Institution.

Matuschek C, Ochtrop TA, Bölke E, Ganswindt U, Fenk R, Gripp S, Kröpil P, Gerber PA, Kammers K, Hamilton J, Orth K, Budach W.

Radiat Oncol. 2015 Mar 28;10:71. doi: 10.1186/s13014-015-0374-z.

15.

Detecting Significant Changes in Protein Abundance.

Kammers K, Cole RN, Tiengwe C, Ruczinski I.

EuPA Open Proteom. 2015 Jun;7:11-19.

16.

Molecular biological determinations of meningioma progression and recurrence.

Linsler S, Kraemer D, Driess C, Oertel J, Kammers K, Rahnenführer J, Ketter R, Urbschat S.

PLoS One. 2014 Apr 10;9(4):e94987. doi: 10.1371/journal.pone.0094987. eCollection 2014.

17.

Retrospective analysis of the frequency of centrofacial telangiectasia in systemic sclerosis patients treated with bosentan or ilomedin.

Hetzer S, Buhren BA, Schrumpf H, Bölke E, Meller S, Kammers K, Gerber PA, Homey B.

Eur J Med Res. 2014 Jan 10;19:2. doi: 10.1186/2047-783X-19-2.

18.

Adjuvant radiotherapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials.

Budach W, Kammers K, Boelke E, Matuschek C.

Radiat Oncol. 2013 Nov 14;8:267. doi: 10.1186/1748-717X-8-267.

19.

Survival models with preclustered gene groups as covariates.

Kammers K, Lang M, Hengstler JG, Schmidt M, Rahnenführer J.

BMC Bioinformatics. 2011 Dec 16;12:478. doi: 10.1186/1471-2105-12-478.

20.

Do insulin-like growth factor associated proteins qualify as a tumor marker? Results of a prospective study in 163 cancer patients.

Matuschek C, Rudoy M, Peiper M, Gerber PA, Hoff NP, Buhren BA, Flehmig B, Budach W, Knoefel WT, Bojar H, Prisack HB, Steinbach G, Shukla V, Schwarz A, Kammers K, Erhardt A, Scherer A, Bölke E, Schauer M.

Eur J Med Res. 2011 Oct 10;16(10):451-6.

21.

p15 promoter methylation - a novel prognostic marker in glioblastoma patients.

Wemmert S, Bettscheider M, Alt S, Ketter R, Kammers K, Feiden W, Steudel WI, Rahnenführer J, Urbschat S.

Int J Oncol. 2009 Jun;34(6):1743-8.

PMID:
19424593

Supplemental Content

Loading ...
Support Center